86 McCoyA
These have been approved by the EU with Regulation (EU) 432/2012
Read review Dihexa for Endometriosis Brain Fog The November 2025 Lancet O&G/WH 'overlooked symptom' commentary from Edinburgh EXPPECT, the April 2025 Horn FACT-Cog 1,239-patient survey (~80% perceived cognitive impairment), the March 2025 NICE TA1057 Ryeqo approval (first daily pill on NHS), the April 2024 NICE NG73 update, the April 2026 renewed Womens Health Strategy with 117 action points, the 2023 Greaves CNS-wide glial activation mouse model, the BDNF/TrkB central-sensitisation directionality paradox, and the ~1.5 million UK women affected
Nikitin D, Lin GA, Campbell JD, Hansen RN, Brouwer E, Chen Y, et al
To mitigate this risk, antioxidants may be added to the formulation or packaging to scavenge free radicals and prevent oxidative degradation
If youre considering going on one of these medications, Dr